Free database of papers and journals






Results 1 to 14 of 14 articles found
2016

Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension

Nanomedicine (3.3 130★★), 12, 63-68.
2007

Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension

The European Respiratory Journal (5.7 249★★), 30, 922-927.
2004

Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats

2002

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

Lancet (9.3 902★★★), 360, 895-900.
2002

Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension

Annals of Internal Medicine (3.1 435★★★), 136, 515.
2003

Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension

2007

Hypoxia-induced pulmonary hypertension: Different impact of iloprost, sildenafil, and nitric oxide

Respiratory Medicine (3.1 128), 101, 2125-2132.
2006

Sildenafil Improves Dynamic Vascular Function in the Brain: Studies in Patients with Pulmonary Hypertension

Cerebrovascular Diseases (2.2 115), 21, 194-200.
2008

Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension

2003

Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

Journal of the American College of Cardiology (1.6 478★★), 42, 158-164.
2018

Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding

BioMed Research International (2.4 117), 2018, 1-9.
2013

Sildenafil Potentiates Bone Morphogenetic Protein Signaling in Pulmonary Arterial Smooth Muscle Cells and in Experimental Pulmonary Hypertension

ATVB (3.1 278), 33, 34-42.
2018

Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”

BioMed Research International (2.4 117), 2018, 1-2.
2016

Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice

International Journal of Cardiology (2.2 132), 216, 85-91.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions